Information Library

Results for: Connect with investigators, regulators and physicians - Targeted communications

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Quintiles Receives ACCME Accreditation With Commendation

    Announcement — September 16, 2011
    As Managing Director, I am pleased to announce that Quintiles Medical Education (QME) has received Accreditation with Commendation as a provider of Continuing Medical Education

  • The Use of Large Simple Trials

    Presentation — February 25, 2011
    Quintiles presentation at CBI Late Phase Conference explores the design and application of Large Simple Trials as a cost effective approach to delivering high quality observational research data.

  • QUINTILES AGAIN NAMED TO INFORMATIONWEEK 500

    Press Release — September 15, 2010 - Quintiles has again been named to the InformationWeek 500, the publication’s annual ranking of the nation’s most innovative users of business technology.

  • Commercial – Identify, Promote and Prove Treatment Value

    Brochure — April 1, 2010
    Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.

  • Medicare Part D’s Effect On Prescribing Volume

    Presentation — June 25, 2009
    Poster presented during the ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) titled “Medicare Part D’s Effect On Prescribing Volume: Average Monthly Utilization of Selected High Use Drugs In The Six Protected Classes, By Different Specialties.”

  • Diabetes Proactive Proposal

    Brochure — June 24, 2009
    New FDA Guidances On Antidiabetic Therapies Change the Landscape of Drug Development. How Quintiles Can Help You Navigate the Guidances and Successfully Develop Pipeline Drug Candidates.

  • Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.

    Presentation — June 24, 2009
    Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) on “The Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.”

Page 1 of 1 (7 results)

Subscribe to Email Based on Your Interests

Set preferences